📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Durability of non-nucleotide reverse transcriptase inhibitor-based first-line ART regimens after 7 years of treatment in rural Uganda: A prospective cohort study. (2021)

First Author: Nanfuka M

Attributed to: Pathogen Genomics, Phenotype and Immunity (PGPI) & Basic Sciences Programme funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1097/md.0000000000025763

PubMed Identifier: 34106606

Publication URI: http://europepmc.org/abstract/MED/34106606

Type: Journal Article/Review

Volume: 100

Parent Publication: Medicine

Issue: 19

ISSN: 0025-7974